Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 5Phase 1/2 2Phase 2/3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 3CNS 3Sarcoma 2Genitourinary 2Gastrointestinal 2Plasma cell 1Head & Neck 1Breast 1

Conditions

Urothelial Carcinoma of the Bladder 1Stage I Prostate Adenocarcinoma AJCC v7 1

Interventions

pembrolizumab 69Docetaxel 50Nivolumab 44Prednisone 34enzalutamide 30Gemcitabine 26Cyclophosphamide 22Cisplatin 22Paclitaxel 21Radiotherapy 19Carboplatin 19Bevacizumab 19Abiraterone Acetate 18Ipilimumab 17atezolizumab 14Magnetic Resonance Spectroscopy 14fludarabine 13aldesleukin 13Sunitinib 13Interleukin-2 12avelumab 11Radiosurgery 11Pluvicto 11Filgrastim 11Everolimus 11gallium 68 PSMA-11 10fludarabine phosphate 10enfortumab vedotin 10durvalumab 10cemiplimab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Proton Therapy × Genitourinary × Clear all
NCT01950351 2025-12-22

Hypofractionated Proton Beam Therapy for Localized Prostate Cancer

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
241 enrolled
Genitourinary

Stage I Prostate Adenocarcinoma AJCC v7

NCT01520038 2019-11-26

Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer

Abramson Cancer Center at Penn Medicine

Phase 1/2 Completed
2 enrolled 12 charts
Genitourinary

Urothelial Carcinoma of the Bladder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡